4A7I
Factor Xa in complex with a potent 2-amino-ethane sulfonamide inhibitor
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | ESRF BEAMLINE ID14-3 |
Synchrotron site | ESRF |
Beamline | ID14-3 |
Temperature [K] | 100 |
Detector technology | CCD |
Collection date | 2005-05-02 |
Detector | ADSC QUANTUM 4r |
Spacegroup name | P 21 21 21 |
Unit cell lengths | 56.253, 72.042, 77.416 |
Unit cell angles | 90.00, 90.00, 90.00 |
Refinement procedure
Resolution | 200.000 - 2.400 |
R-factor | 0.198 |
Rwork | 0.198 |
R-free | 0.25300 |
Structure solution method | MOLECULAR REPLACEMENT |
Starting model (for MR) | UNPUBLISHED FACTOR XA STRUCTURE |
RMSD bond length | 0.005 |
RMSD bond angle | 1.323 |
Data reduction software | XDS |
Data scaling software | XSCALE |
Phasing software | CNX (RIGID BODY REFINEMENT) |
Refinement software | CNS (2002) |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 19.660 | 2.480 |
High resolution limit [Å] | 2.400 | 2.400 |
Rmerge | 0.040 | 0.200 |
Number of reflections | 12692 | |
<I/σ(I)> | 21 | 6 |
Completeness [%] | 99.0 | 100 |
Redundancy | 3.6 | 3.5 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | 5.7 | PROTEIN SOLUTION: 8 MG/ML PROTEIN, 5 MM MES (PH 5.7), 5 MM CACL2, 100 MM BENZAMIDINE. RESERVOIR: 18-20% PEG-600, 50 MM MES (PH 5.7). SOAKING: ADD 10 MM INHIBITOR. |